Trigonella hamosa saponins (SS) were purified using Sephadex LH-20. The effects of SS on diabetes, lipid profiles and glucose homeostasis were investigated by supplementation of the diet of rats with SS, which countered the adverse, harmful effects of chronic diabetes by improving insulin synthesis, secretion and action, enhancing lipid and protein metabolism, and removing the oxidative stress concomitant with glucose homeostasis.
Trigonella hamosa L. (Trigonella glabra Thumb.) is an annual coumarin-smelling herb that grows as a weed in Egypt, the East Mediterranean region, and from Arabia to Afghanistan and India [1] . We selected this plant on the basis of the great interest shown in fenugreek (Trigonella foenum graecum L.), a pharmaceutical herb of world wild distribution. Over the past few years, fenugreek has been shown to display hypocholesterolemic [2] and anti-diabetic effects [3] . Only little phytochemical research has been carried out on the seeds of T. hamosa which revealed the presence of furostane saponins [4] .
As part of our studies for developing new sources of medicinal plants, we have evaluated the protective role of T. hamosa saponins against diabetic perturbations and complications in rats. For this purpose, we first extracted and purified T. hamosa saponins and secondly, we investigated in vivo, in normal and diabetic rats, the effects of administration of T. hamosa saponins on the metabolic-endocrine changes, lipid profile metabolism and glucose homeostasis and their role in scavenging and suppression of the dramatic diabetic complications.
Rats were divided into four groups; two control groups either without (C) or with saponins (SS) supplement, and two diabetic groups treated with either streptozotocin only (STZ) or supplemented with saponins after streptozotocin treatment (STZ+SS). Treatment was continued for one month and major parameters such as blood glucose, insulin and cholesterol levels were initially checked and then at different time intervals (5, 10, 20 , and 30 days).
As shown in Figure 1 , glucose levels in the diabetic group (STZ) and saponins-treated diabetic rats (STZ+SS) showed highly significant (p ≤ 0.01) increases after 5, 10, 20 and 30 days compared to the control groups (C and SS). Treatment of diabetic rats with saponins (STZ+SS) produced a significant decrease in the glucose level compared with the diabetic (STZ) group after 20 and 30 days of treatment.
Streptozotocin induced a significant reduction in the insulin levels of the diabetic group (STZ) and of the saponins-treated diabetic one (STZ+SS) after 10, 20, and 30 days, as shown in Figure 2 . On the other hand, in the diabetic rats (STZ+SS), the saponins decreased the dramatic effects and restored part of the insulin level after 20 and 30 days.
As shown in Figure 3 , total cholesterol (TC) levels were elevated significantly after 20 and 30 days of treatment in the STZ and STZ+SS groups, but the levels in the STZ+SS group were significantly lower than those of the STZ group after 30 days only.
It is clear from the previous results that the harmful effects of chronic diabetes appeared after 20 days and reached a maximum after 30 days of treatment. As a result, a detailed study on how supplementation of the diet of rats with saponins countered the adverse, harmful effects of chronic diabetes on lipid and protein metabolism was carried out after one month of treatment.
Glucose homeostasis by improving insulin synthesis: Serum glucose, insulin, TNFα and blood HbA1c levels are shown in Table 1 . The glucose 
levels in the controls (C and SS) were significantly lower (p ≤ 0.01) than those in the diabetic group (STZ) resulting from the reduction of the insulin level in the diabetic group. Moreover, the HbA1c percentage increased significantly in the diabetic group, which was accompanied by a significant increase in the TNFα level. On the other hand, treatment of the diabetic rats with T. hamosa saponins (STZ+SS) decreased the dramatic effects and restored part of the insulin level (significant differences between this group and the control and STZ groups). The T. hamosa saponins in the STZ+SS group also had a significant effect on glucose, HbA1c and TNFα levels when compared with the untreated diabetic (STZ) group, although all these values were still significantly higher than the control groups (C or SS).
Serum lipid metabolism profile: Total lipid (TL), total triglycerides (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDLc) and high density lipoprotein cholesterol (HDLc) levels are shown in Table 2 . The data show significant increases in the levels of the lipid profile in both the STZ and STZ+SS groups in comparison with the controls (C and SS). Treatment of the diabetic rats with T. hamosa saponins (STZ+SS) decreased these values significantly when compared with the untreated diabetic (STZ) group. By comparing the STZ group with the diabetic group treated with saponins (STZ+SS), the TL, TC and LDLc decreased significantly, whereas the HDLc increased significantly, and there was no significant difference in the TG. No significant differences in TL, TG, TC, LDLc, and HDLc were found between the control groups (C and SS).
Protein metabolism profile: Serum total protein (TP) concentration showed a significant decrease in diabetic rats (STZ) in comparison with both controls (C and SS), and the diabetic treated (STZ+SS) groups. There was no significant difference between the two control groups (C and SS) and the diabetic treated (STZ+SS) one. However, serum urea concentration was significantly higher in both the diabetic STZ and STZ+SS groups in comparison with the controls (C and SS). There was no significant difference between the STZ and STZ+SS groups.
Transaminase activity (ALT, AST and γGT) was significantly increased in the diabetic rats (STZ) in comparison with the controls, but only ALT and γGT in the STZ+SS group. The STZ+SS group, on the other hand, when compared with the untreated diabetic group (STZ) showed significant decreases in ALT and AST, while γGT was non-significantly different.
The results obtained demonstrated the dramatic complications that are associated with diabetes. In comparison with the control groups, there were significant increases in the levels of serum glucose, TNFα and HbA1c, and a significant decrease in serum insulin as a consequence of STZ diabetes induction. T. hamosa saponin treatment curtailed the magnitude of the diabetic complications, as shown by the significant increase in the insulin level and the significant decreases in glucose, HbA1c and TNFα in comparison with the diabetic non-treated group.
Hancu [5] reported that high glucose concentrations increase the production capacity of tumor necrosis factor alpha (TNFα) by human peripheral blood mononuclear cells. TNFα is recognized as a key for insulin resistance and there is an inverse relationship between insulin and TNFα. However, surplus production has proved to occasion insulin resistance and decrease glucose transporters [6] . Our results on T. hamosa saponins supplementation support these reports. A significant increase of HbA1c means glycation of proteins (glucose protein interaction), which increases progressively with the extent of diabetes and this may alter the shape and function of internal protein and enhance the development of complications [7] . Also, the metabolic control of diabetes is measured by the level of HbA1c, but this may be ameliorated by T. hamosa saponins treatment, as demonstrated by the results obtained.
Abnormal lipid, especially fatty acid oxidation, is the key to pathogenesis of diabetes characterized by the accumulation of triglycerides, which enhance the reduction of the insulin stimulation effect on glucose metabolism and produce oxidative stress [8] . The lipid profile showed a significant increase of: TL, TG, TC, and LDLc, but significant decrease of HDLc in all diabetic rats in comparison with controls.
On the other hand diabetic animals supplemented with T. hamosa saponins showed significant decreases in the levels of TL, TG, TC, and LDLc, but an increase in HDLc when compared with nontreated diabetic rats. This differs from earlier findings [8, 9] that suggested that T. hamosa saponins may act as a scavenger for the harmful STZ diabetic effects and as a modulator for oxidative free radicals produced from fatty acids oxidation and increasing of HDLc secretion, as well as a lowering effect on LDLc in both diabetic and hypercholestermic diet fed animals. As LDLc is the major carrier of cholesterol towards the tissues from the liver, it has an atherogenic potential. On the other hand, HDLc is a carrier of cholesterol to the liver from tissues and protects against atherosclerosis [10] . In this respect also, it was suggested [8, 11] that fatty liver is common in diabetics and is related to the increase in levels of fatty acids and triglycerides, which decrease the tonic inhibition of insulin for endogenous glucose production, impair glucose cycling and increase insulin resistance. Moreover, oxidative stress and accumulation of oxidative free radicals are concomitant with diabetes and responsible for hyperglycemia induced tissue damage.
The protein metabolism profile is greatly affected by the severity of diabetes as a consequence of abnormalities of lipid metabolism that cause protein wasting and increased morbidity and mortality [12] .
The obtained results showed a significant decrease in TP level, but significant increases in serum urea, ALT, AST, and γGT, when compared with the controls, but there was a significant decrease of serum ALT and AST of diabetic rats treated with T. hamosa saponins in comparison with untreated diabetic rats. Total protein content showed a slight increase, while urea and γGT levels slightly decreased. The present findings agree with the reports that diabetes is characterized by metabolic disorders induced by hepatocellular damage and impaired liver functions [13] . Transaminases activity, protein catabolism and urea production has been used to assess the toxic effects of hypoglycemic xenobiotics on liver, pancreas, kidney and muscle [12, 14] . In addition, saponins treatment increased the TP level and decreased liver enzymes, indicating the hepatoprotective effect of T. hamosa saponins, which is essential for nucleic acids and protein [15] .
In conclusion, it is clear that supplementation of the diet of diabetic rats with T. hamosa saponins countered some of the adverse, harmful effects of chronic diabetes by improving insulin synthesis, secretion and action by enhancing better lipid and protein metabolism and removing oxidative stress concomitant with glucose homeostasis.
Experimental
Plant material: Seeds of Trigonella hamosa were collected from Aswan Governorate (South Egypt) in March 2005 and identified by the author according to [1] . The voucher specimen was deposited at the herbarium of the Botany Faculty of Science, Aswan, Egypt.
Extraction and isolation of the saponins fraction:
The dried ground seeds (500 g) were defatted with n-hexane and the residue extracted with EtOH 80% three times, yielding 40 g of extract. Each gram of the ethanolic extract was applied onto a Sephadex LH-20 column (50 x 5 cm) and eluted stepwise with H 2 O (A-1), 20% methanol (A-2), 40% methanol (A-3), 75% methanol (A-4, saponins portion, 200 mg) and 100% methanol (A-5). The obtained data are expressed as means ± standard error (X ± SE). To determine differences among the treated groups, data were statistically analyzed using a computerized one-way ANOVA followed a by t-test, according to [16n] . Differences between means were considered significant with a value of P ≤ 0.05.
